EMEA-001005-PIP01-10-M01

Key facts

Invented name
Kaletra
Active substance
  • lopinavir
  • ritonavir
Therapeutic area
Infectious diseases
Decision number
P/0144/2012
PIP number
EMEA-001005-PIP01-10-M01
Pharmaceutical form(s)
  • Oral solution
  • Soft capsule
  • Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
AbbVie Ltd
United Kingdom
E-mail: ukpaediatricteam@abbvie.com
Tel. +44 (0)1628 408248
Fax +44 (0)1628 672551
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-001005-PIP01-10-M01
Compliance opinion date
17/07/2015
Compliance outcome
positive

Decision

How useful was this page?

Add your rating